Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver

Rheumatoid arthritis (RA) is a chronic inflammatory disease, leading to progressive destruction of joints and extra-articular tissues, including organs such as liver and spleen. The purpose of this study was to compare the effects of a potential immunomodulator, natural polyphenol N-feruloylserotoni...

Full description

Saved in:
Bibliographic Details
Main Authors: Ľudmila Pašková, Viera Kuncírová, Silvester Poništ, Danica Mihálová, Radomír Nosáľ, Juraj Harmatha, Iveta Hrádková, Tomáš Čavojský, František Bilka, Katarína Šišková, Ingrid Paulíková, Lýdia Bezáková, Katarína Bauerová
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2016/7509653
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556239816491008
author Ľudmila Pašková
Viera Kuncírová
Silvester Poništ
Danica Mihálová
Radomír Nosáľ
Juraj Harmatha
Iveta Hrádková
Tomáš Čavojský
František Bilka
Katarína Šišková
Ingrid Paulíková
Lýdia Bezáková
Katarína Bauerová
author_facet Ľudmila Pašková
Viera Kuncírová
Silvester Poništ
Danica Mihálová
Radomír Nosáľ
Juraj Harmatha
Iveta Hrádková
Tomáš Čavojský
František Bilka
Katarína Šišková
Ingrid Paulíková
Lýdia Bezáková
Katarína Bauerová
author_sort Ľudmila Pašková
collection DOAJ
description Rheumatoid arthritis (RA) is a chronic inflammatory disease, leading to progressive destruction of joints and extra-articular tissues, including organs such as liver and spleen. The purpose of this study was to compare the effects of a potential immunomodulator, natural polyphenol N-feruloylserotonin (N-f-5HT), with methotrexate (MTX), the standard in RA therapy, in the chronic phase of adjuvant-induced arthritis (AA) in male Lewis rats. The experiment included healthy controls (CO), arthritic animals (AA), AA given N-f-5HT (AA-N-f-5HT), and AA given MTX (AA-MTX). N-f-5HT did not affect the body weight change and clinical parameters until the 14th experimental day. Its positive effect was rising during the 28-day experiment, indicating a delayed onset of N-f-5HT action. Administration of either N-f-5HT or MTX caused reduction of inflammation measured as the level of CRP in plasma and the activity of LOX in the liver. mRNA transcription of TNF-α and iNOS in the liver was significantly attenuated in both MTX and N-f-5HT treated groups of arthritic rats. Interestingly, in contrast to MTX, N-f-5HT significantly lowered the level of IL-1β in plasma and IL-1β mRNA expression in the liver and spleen of arthritic rats. This speaks for future investigations of N-f-5HT as an agent in the treatment of RA in combination therapy with MTX.
format Article
id doaj-art-072222128a704d429b0ad2a1c2b52eef
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-072222128a704d429b0ad2a1c2b52eef2025-02-03T05:45:57ZengWileyJournal of Immunology Research2314-88612314-71562016-01-01201610.1155/2016/75096537509653Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in LiverĽudmila Pašková0Viera Kuncírová1Silvester Poništ2Danica Mihálová3Radomír Nosáľ4Juraj Harmatha5Iveta Hrádková6Tomáš Čavojský7František Bilka8Katarína Šišková9Ingrid Paulíková10Lýdia Bezáková11Katarína Bauerová12Department of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, SlovakiaInstitute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, 841 04 Bratislava, SlovakiaInstitute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, 841 04 Bratislava, SlovakiaInstitute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, 841 04 Bratislava, SlovakiaInstitute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, 841 04 Bratislava, SlovakiaInstitute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 166 10 Prague, Czech RepublicFaculty of Food and Biochemical Technology, University of Chemistry and Technology, 166 28 Prague, Czech RepublicDepartment of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, SlovakiaDepartment of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, SlovakiaDepartment of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, SlovakiaDepartment of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, SlovakiaDepartment of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, SlovakiaInstitute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, 841 04 Bratislava, SlovakiaRheumatoid arthritis (RA) is a chronic inflammatory disease, leading to progressive destruction of joints and extra-articular tissues, including organs such as liver and spleen. The purpose of this study was to compare the effects of a potential immunomodulator, natural polyphenol N-feruloylserotonin (N-f-5HT), with methotrexate (MTX), the standard in RA therapy, in the chronic phase of adjuvant-induced arthritis (AA) in male Lewis rats. The experiment included healthy controls (CO), arthritic animals (AA), AA given N-f-5HT (AA-N-f-5HT), and AA given MTX (AA-MTX). N-f-5HT did not affect the body weight change and clinical parameters until the 14th experimental day. Its positive effect was rising during the 28-day experiment, indicating a delayed onset of N-f-5HT action. Administration of either N-f-5HT or MTX caused reduction of inflammation measured as the level of CRP in plasma and the activity of LOX in the liver. mRNA transcription of TNF-α and iNOS in the liver was significantly attenuated in both MTX and N-f-5HT treated groups of arthritic rats. Interestingly, in contrast to MTX, N-f-5HT significantly lowered the level of IL-1β in plasma and IL-1β mRNA expression in the liver and spleen of arthritic rats. This speaks for future investigations of N-f-5HT as an agent in the treatment of RA in combination therapy with MTX.http://dx.doi.org/10.1155/2016/7509653
spellingShingle Ľudmila Pašková
Viera Kuncírová
Silvester Poništ
Danica Mihálová
Radomír Nosáľ
Juraj Harmatha
Iveta Hrádková
Tomáš Čavojský
František Bilka
Katarína Šišková
Ingrid Paulíková
Lýdia Bezáková
Katarína Bauerová
Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver
Journal of Immunology Research
title Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver
title_full Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver
title_fullStr Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver
title_full_unstemmed Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver
title_short Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver
title_sort effect of n feruloylserotonin and methotrexate on severity of experimental arthritis and on messenger rna expression of key proinflammatory markers in liver
url http://dx.doi.org/10.1155/2016/7509653
work_keys_str_mv AT ludmilapaskova effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver
AT vierakuncirova effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver
AT silvesterponist effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver
AT danicamihalova effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver
AT radomirnosal effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver
AT jurajharmatha effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver
AT ivetahradkova effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver
AT tomascavojsky effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver
AT frantisekbilka effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver
AT katarinasiskova effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver
AT ingridpaulikova effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver
AT lydiabezakova effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver
AT katarinabauerova effectofnferuloylserotoninandmethotrexateonseverityofexperimentalarthritisandonmessengerrnaexpressionofkeyproinflammatorymarkersinliver